mebikar has been researched along with Anxiety Neuroses in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, K; Kim, CY; Kim, D; Kim, YG; Koo, H; Sin, SJ | 1 |
| Il'ina, DIu; Treshkur, TV; Tsurinova, EA | 1 |
| Lempert, BA; Shilina, NN; Sporova, OE; Statsenko, ME | 1 |
| Anisimova, TI; Chutko, LS; Iakovenko, EA; Nikishena, IS; Rozhkova, AV; Surushkina, SIu | 1 |
| Anisimova, TI; Bykova, IuL; Chutko, LS; Iakovenko, EA; Iur'eva, RG; Nikishena, IS; Surushkina, SIu | 1 |
| Chutko, LS; Rozhkova, AV; Sidorenko, VA; Surushkina, SIu; Tursunova, KB | 1 |
| Marchenko, AA; Puliatkina, OV; Samartsev, IN; Zhivolupov, SA | 1 |
| Solomasova, AA; Zavadenko, NN | 1 |
5 trial(s) available for mebikar and Anxiety Neuroses
| Article | Year |
|---|---|
[Efficacy of adaptol and the possibility of its differential use in patients with anxiety disorders after myocardial infarction].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Biureas; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Treatment Outcome | 2013 |
[Clinical and neurophysiological study of the efficacy of adaptol in the treatment of emotional burn-out].
Topics: Adult; Anxiety Disorders; Beta Rhythm; Biureas; Brain; Burnout, Professional; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Treatment Outcome | 2010 |
[Cognitive disturbances in children with anxiety-phobic disorders].
Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Biureas; Child; Cognition Disorders; Female; Humans; Male; Phobic Disorders; Treatment Outcome | 2011 |
[The prognostic significance of brain-derived neurotrophic factor (BDNF) for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Autonomic Nervous System Diseases; Biureas; Brain-Derived Neurotrophic Factor; Cognition Disorders; Dose-Response Relationship, Drug; Humans; Middle Aged; Phobic Disorders; Prognosis; Treatment Outcome; Young Adult | 2012 |
[Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options].
Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Biureas; Child; Comorbidity; Female; Humans; Male; Treatment Outcome | 2012 |
3 other study(ies) available for mebikar and Anxiety Neuroses
| Article | Year |
|---|---|
Preventive Effect of Mebicar and Ginsenoside Rg1 on Neurobehavioral and Immunological Disruptions Caused by Intermittent Unpredictable Stress in Mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Biureas; Cells, Cultured; Central Nervous System Agents; Ginsenosides; Locomotion; Male; Mice; Mice, Inbred BALB C; Stress, Psychological | 2018 |
[A case of effective psychogenic ventricular arrhythmia treatment with the anxiolytic Adaptol].
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Arrhythmias, Cardiac; Biureas; Electrocardiography, Ambulatory; Female; Heart Ventricles; Humans; Stress, Psychological; Treatment Outcome | 2013 |
[Generalized anxiety disorder: psychosomatic aspects and treatment approaches].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biureas; Female; Humans; Male; Middle Aged; Psychophysiologic Disorders; Treatment Outcome; Young Adult | 2012 |